BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22008135)

  • 1. [Significance of 3-methoxytyramine urine measurement in the diagnosis of pheochromocytomas and paragangliomas: about 28 patients].
    Le Jacques A; Abalain JH; Le Saos F; Carré JL
    Ann Biol Clin (Paris); 2011; 69(5):555-9. PubMed ID: 22008135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low specificity of urinary 3-methoxytyramine in screening of dopamine-secreting pheochromocytomas and paragangliomas.
    Patin F; Crinière L; Francia T; Kassem S; Pierre P; Bruno C; Vayne C; Vourc'h P; Benz-de Bretagne I; Andres CR; Blasco H
    Clin Biochem; 2016 Oct; 49(15):1205-1208. PubMed ID: 27208558
    [No Abstract]   [Full Text] [Related]  

  • 3. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
    Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
    Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
    Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
    Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias.
    Martínez-Morillo E; Valdés Gallego N; Eguia Ángeles E; Fernández Fernández JC; Prieto García B; Álvarez FV
    Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
    Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
    Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory evaluation of pheochromocytoma and paraganglioma.
    Eisenhofer G; Peitzsch M
    Clin Chem; 2014 Dec; 60(12):1486-99. PubMed ID: 25332315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological diagnosis of pheochromocytoma: is there an interest in urinary metanephrines measurement over 3 consecutive days?].
    Bettacchioli É; Leven C; Thuillier P; Plée-Gautier E; Lapègue M; Carré JL; Padelli M
    Ann Biol Clin (Paris); 2018 Oct; 76(5):537-544. PubMed ID: 30174318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Urinary Catecholamine Excretion and Urine Volume.
    Haap M; Blaschka F; Lehmann R; Hoyer A; Müssig K
    Horm Metab Res; 2019 Aug; 51(8):531-538. PubMed ID: 31174227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
    Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
    Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine.
    Eisenhofer G; Goldstein DS; Sullivan P; Csako G; Brouwers FM; Lai EW; Adams KT; Pacak K
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2068-75. PubMed ID: 15644397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated
    Eisenhofer G; Prejbisz A; Peitzsch M; Pamporaki C; Masjkur J; Rogowski-Lehmann N; Langton K; Tsourdi E; Pęczkowska M; Fliedner S; Deutschbein T; Megerle F; Timmers HJLM; Sinnott R; Beuschlein F; Fassnacht M; Januszewicz A; Lenders JWM
    Clin Chem; 2018 Nov; 64(11):1646-1656. PubMed ID: 30097498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma.
    Bokuda K; Yatabe M; Seki Y; Ichihara A
    Hypertens Res; 2020 Jun; 43(6):543-549. PubMed ID: 32020083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors.
    de Jong WH; Eisenhofer G; Post WJ; Muskiet FA; de Vries EG; Kema IP
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2841-9. PubMed ID: 19567530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population.
    Brain KL; Kay J; Shine B
    Clin Chem; 2006 Nov; 52(11):2060-4. PubMed ID: 16990424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas.
    Sbardella E; Maunsell Z; May CJH; Tadman M; James T; Jafar-Mohammadi B; Isidori AM; Grossman AB; Shine B
    Eur J Endocrinol; 2020 Aug; 183(2):129-139. PubMed ID: 32413848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary normetanephrine and metanephrine measured by radioimmunoassay for the diagnosis of pheochromocytoma: utility of 24-hour and random 1-hour urine determinations.
    Oishi S; Sasaki M; Ohno M; Sato T
    J Clin Endocrinol Metab; 1988 Sep; 67(3):614-8. PubMed ID: 3410942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.